Form D · Pharmaceuticals
Salerno Pharmaceuticals, LP
Newport Beach, CA · CIK 0001694399
Offering snapshot reported Jul 31, 2019 · SEC filing
- Reported sold
- $625K Offering amount: $1.83M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 19, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 31, 2019 | Initial | $625,437 | No comparison | 11 | SEC filing |
| Feb 27, 2017 | Amendment | $5,493,236 | $2,533,236vs Jan 13, 2017 | 41 | SEC filing |
| Jan 13, 2017 | Initial | $2,960,000 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-345477
Source: Form D, filed Jul 31, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas W. Courtney, Jr. | Executive |
| Edward Mc Kenna | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
610 Newport Center Drive Suite 330
Newport Beach, CA, 92660
Newport Beach, CA, 92660